• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CG Oncology, Inc. - Common stock (NQ:CGON)

41.85 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CG Oncology, Inc. - Common stock

< Previous 1 2 Next >
Why Cg Oncology Stock Rocketed 7% Higher Today
October 08, 2025
One pundit believes this is a clinical-stage company well worth watching. 
Via The Motley Fool
CG Oncology Stock Signals Bullish Momentum Ahead
September 08, 2025
CG Oncology has entered its Phase 2 of the Adhishthana Cycle, signaling a bullish setup. With momentum already building, here's what to track... 
Via Benzinga
Cg Oncology (CGON) Q2 Loss Widens 93%
August 08, 2025
Via The Motley Fool
Which stocks are moving before the opening bell on Tuesday?
July 22, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
3 Analysts Assess CG Oncology: What You Need To Know
March 07, 2025
 
Via Benzinga
Why CG Oncology (CGON) Stock Is Down 9%
December 11, 2024
CG Oncology shares are trading lower by 9.2% during Wednesday's session. The company announced it filed an underwritten public offering of 7.3 million shares of its common stock. 
Via Benzinga
Demystifying CG Oncology: Insights From 7 Analyst Reviews
December 06, 2024
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 22, 2025
 
Via Benzinga
Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock
July 16, 2025
 
Via Benzinga
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
May 04, 2025
Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them? 
Via Benzinga
Topics Artificial Intelligence
These stocks are moving in today's session
April 28, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
A Closer Look at 9 Analyst Recommendations For CG Oncology
June 28, 2024
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 28, 2025
 
Via Benzinga
Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook
April 28, 2025
 
Via Benzinga
Which stocks are gapping on Monday?
April 28, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why
April 28, 2025
CG Oncology shared new Phase 3 trial results showing durable responses and strong patient compliance in high-risk bladder cancer treatment at AUA 2025. 
Via Benzinga
These stocks are moving in today's pre-market session
April 28, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday
April 28, 2025
 
Via Benzinga
CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug
April 28, 2025
The companies are working on treatments for a form of bladder cancer. 
Via Investor's Business Daily
Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings
April 28, 2025
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 28, 2025
 
Via Benzinga
This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
April 16, 2025
 
Via Benzinga
Friday's after hours session: top gainers and losers
April 11, 2025
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
Expert Outlook: CG Oncology Through The Eyes Of 4 Analysts
March 25, 2025
 
Via Benzinga
ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug
March 06, 2025
HC Wainwright initiates coverage on ImmunityBio with a Buy rating, citing Anktiva's growth potential. The firm projects $4.3 billion in sales, up from $137M in 2025. 
Via Benzinga
Nasdaq Jumps 300 Points To Record Highs
December 11, 2024
Stocks are higher this afternoon, after this morning's highly-anticipated CPI report met expectations. 
Via Talk Markets
Topics Stocks / Equities
CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate
December 05, 2024
CG Oncology's BOND-003 trial reveals durable efficacy of cretostimogene in NMIBC patients, with median DOR exceeding 27 months and no severe side effects. 
Via Benzinga
Discover the 3 Best-Performing Biotech IPO Stocks of 2024
November 06, 2024
Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise. 
Via MarketBeat
Topics Initial Public Offering
This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
October 24, 2024
 
Via Benzinga
CGON Stock Earnings: CG Oncology Beats EPS for Q2 2024
August 08, 2024
CGON stock results show that CG Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap